(Q81425267)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Comparison of two assays for fibroblast growth factor (FGF)-23 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Nobuaki Ito

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Seiji Fukumoto

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yasuhiro Takeuchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Toshiyuki Yasuda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yukihiro Hasegawa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Fumi Takemoto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Toshihiro Tajima

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Kazushige Dobashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Yuji Yamazaki

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Takeyoshi Yamashita

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Toshiro Fujita

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

Journal of Bone and Mineral Metabolism

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

435-440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00774-005-0625-4

8 January 2020

exact match

0 references

cites work

Serum FGF23 levels in normal and disordered phosphorus homeostasis.

1 reference

12 December 2020

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

1 reference

12 December 2020

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

1 reference

12 December 2020

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

12 December 2020

Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin

1 reference

12 December 2020

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

1 reference

12 December 2020

Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent

1 reference

12 December 2020

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

1 reference

12 December 2020

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

1 reference

12 December 2020

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

1 reference

12 December 2020

Phosphatonin--a new phosphaturetic hormone? (lessons from tumour-induced osteomalacia and X-linked hypophosphataemia)

1 reference

12 December 2020

MEPE has the properties of an osteoblastic phosphatonin and minhibin.

1 reference

12 December 2020

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

12 December 2020

10.1007/S00774-005-0625-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16261449%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference